SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Activity

5 hedge funds and large institutions have $1.02M invested in Sonnet BioTherapeutics in 2013 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$667K
2
BIT
2
BlackRock Institutional Trust
California
$134K
3
CDH
3
Charles D. Hyman
$133K
4
Bank of America
4
Bank of America
North Carolina
$64K
5
TRCT
5
Tower Research Capital (TRC)
New York
$18K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
Millennium Management
1
Millennium Management
New York
$667K 222,222 +222,222 New
BIT
2
BlackRock Institutional Trust
California
$134K 44,640 +44,640 New
CDH
3
Charles D. Hyman
$133K 44,444 +44,444 New
Bank of America
4
Bank of America
North Carolina
$64K 21,428 +21,428 New
TRCT
5
Tower Research Capital (TRC)
New York
$18K 5,900 +5,900 New